Earn CME: https://naccme.com/program/19-gdugi-3 In this webcast from the ‘Chemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability’ symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Christopher L. Hallemeier argues in favor of utilizing stereotactic body radiation therapy (SBRT) for the preoperative treatment of borderline resectable pancreatic cancer. รยฉ 2019 Imedex, an HMP Company
Advertisement